Trial Profile
A randomized, controlled, prospective trial examining the effectiveness of two insulin titration algorithms of long acting insulin (insulin glargine, Lantus or insulin detemir, Levemir) in subjects with Type 2 Diabetes mellitus treated with metformin or DPP4 inhibitors
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Mar 2016 Status changed from recruiting to discontinued as per European Clinical Trials Database record.
- 01 Aug 2014 New trial record